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Abstract
Background: Calculus Bovis (:C.Bovis) is one of the most precious and commonly-used medicinal materials in Japan
and China. As the natural occurrence is very rare, a source of supply for C. Bovis is far behind the actual need and
great efforts have been taken for some substitutes of natural C. Bovis. Unfortunately, very little information is
available on the quality and/or clinical efficacy of medication based on C. Bovis. To ensure sustainable use of
traditional therapeutic agents derived from C. Bovis, we felt that several issues needed to be addressed: 1) the
source of the C. Bovis materials and quality control; 2) the role of taurine in the efficacy of C. Bovis.
Methods: Nine samples of natural C. Bovis and its substitutes were collected. ICP-MS was used for elemental
analysis and the characterization was performed by principal component analysis (PCA) and soft independent
modeling of class analogy (SIMCA) as multivariate approaches. The efficacy of C. Bovis was evaluated for
morphology, viability and beating pattern on cultured cardiac myocytes and/or fibroblasts.
Results: PCA and multi-elemental focus was effective in discriminating C. Bovis samples derived from different
habitats. A satisfactory classification using SIMCA was obtained among Australia C. Bovis, other habitats and the
substitutes. Australian samples had better batch uniformity than other habitats and were composed of fewer
elements. We have used Australian C. Bovis for assessment on its bioactive compounds. Rat cardiac cells incubated
with C. Bovis extract (0.01-0.1mg/ml) maintained normal morphology, viability and beating pattern. Cardiac
myocytes and fibroblasts treated for 48 h with CA (0.5mM) or DCA (0.1mM) caused cell injury, as reflected by
changes in appearance and a reduction of viability detected by the MTS assay. In cardiomyocytes, 0.5 h exposure
of CA (0.5mM) markedly decreased the velocity ratio of beating, whereas the simultaneous addition of 1 mM
taurine largely prevented the decrease.
Conclusions: The multi-elemental focus provided some references for the quality control and the efficacy of
C. Bovis. Taurine partly attenuated the harmful actions of bile acids. It is plausible that the relationship between
taurine and the bile acids contributes to therapeutic effect of C. Bovis.
Background
Calculus Bovis (Goo in Japanese, Niuhuang in Chinese,
the gallstone of Bos Taurus domesticus Gmmelin) is one
of the most precious and commonly-used medicinal
materials in Japan and China. Its use was first recorded
in “Shennong Bencao Jing” (Divine Farmer’s Materia
Medica Classic) more than two thousand years ago, and
now it has been used in 650 out of the 4500 traditional
Chinese medicines [1,2]. In the 230 cardioactive types of
Japanese OTC drugs, 228 drugs contain C. Bovis, which
has the effects of sedation, anti-hyperspasmia, relieving
fever, diminishing inflammation and normalizing func-
t i o no ft h eg a l l b l a d d e r[ 3 , 4 ] .As o u r c eo fs u p p l yf o r
C. Bovis is far behind the actual need since the natural
occurrence of C. Bovis is very rare. In China, great
efforts have been taken for some substitutes of natural
C. Bovis. The safety and efficacy of C. Bovis is closely
correlated with quality of the source materials. Unfortu-
nately, very little information is available on the quality
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tional animal sources.
We have previously reported on the anti-arrhythmic
actions of C. Bovis as a traditional knowledge-product
and suggested these effects are partly mediated by taur-
ine [3]. To ensure sustainable use of traditional thera-
peutic agents derived from C. Bovis, we felt that several
issues needed to be addressed: 1) the source of the
C. Bovis preparation and quality control; 2) the role of
taurine in the cardio-active efficacy of C. Bovis.
Materials and methods
Samples and reagents
Thirteen samples of natural C. Bovis and its substitutes
(artificial C. Bovis, cultured C. Bovis) from various places
were collected and are listed in Table 1. Nine batches of
natural C. Bovis samples produced from Australia,
Argentina, Brazil, Guatemala, Mexico and Kenya were
purchased from Tochimoto Tenkai-Do (Osaka, Japan).
All materials used in this study were stored in the
Department of Applied Pharmacognosy, the Museum of
Osaka University, Japan. Cholic acid (CA), deoxycholic
acid (DCA) and glycine-/taurine-conjugated bile acids
were purchased from Nacalai Tesque, Inc. (Kyoto,
Japan). Other regents were of analytical grade.
Preparation of Calculus. Bovis-extract and taurine
measurement
Water or DMSO was used as the solvent to extract the
desired components. Natural C. Bovis contains a high
concentration of bile acid, which adversely affects cells
by disrupting their cell membrane. Each concentration
of major bile acids in C. Bovis (100% DMSO) was
equivalent to 0.5 mM CA, 0.1 mM DCA and 0.5 mM
taurocholic acid (:TCA), respectively [3]. To minimize
the extraction of these bile acids, water or DMSO/water
(=2:1) was used as the solvent to extract the desired
components. Ten mg of well-pulverized crude drug was
extracted with 5 ml of water at room temperature. The
extract was centrifuged at 12000 x g for 20 min at 4°C.
A final concentration of C.Bovis extract to the culture
medium was 0.01-0.1mg/ml according to the human
OTC doses.
The taurine or bile acids content of C. Bovis derived
samples was measured by the procedure using ultra per-
formance liquid chromatography (LaChromUltra, HITA-
CHI, Inc., Tokyo, Japan) equipped with a L-2485U
fluorescence detector or L-2400U UV detector,
respectively.
ICP-MS measurement and multivariate analysis
Major and trace elements in materials were measured by
using inductively coupled plasma mass spectrometry
(:ICP-MS) [5]. The C. bovis powder (10 mg) was added
to 1ml of HNO3 (Nacalai Tesque, Kyoto, Japan), vor-
texed and left standing overnight at room temperature.
Then, 100μl of samples were diluted with 9.9 ml of
water and filtered through 0.45 μm pore size hydrophilic
PTFE membrane filter (Millip o r e ,B i l l e r i c a ,M A ) .I C P -
MS analysis was performed on the Agilent 7500 Series
ICP-MS (Agilent Technologies, Inc., Santa Clara, CA).
Among the attained data, the elements which were
detected as more than 1μg/l in the solvent were
selected. Each data in the chart was shown as relative
concentration. Principal component analysis (PCA) and
soft independent modeling of class analogy (SIMCA)
were used as exploratory techniques and classification
procedures, respectively [6]. Variables such as Na, Mg,
A l ,K ,C a ,V ,C r ,M n ,F e ,C o ,N i ,C u ,Z n ,G e ,A s ,M o ,
Hg and Pb have been used as discriminating factors.
Table 1 Summary of investigated samples
No. Species Properties Source Collection site Collection date
1 Natural C.bovis Natural, PW
1) Tochimoto co. Australia-1 2006
2 Natural C.bovis Natural, PW Tochimoto/Toyama Australia-2 2001
3 Natural C.bovis Natural, PW Tochimoto/Toyama Argentine 2001
4 Natural C.bovis Natural, PW Tochimoto/Toyama Brazil 2001
5 Natural C.bovis Natural, PW Tochimoto/Toyama Guatemala 2001
6 Natural C.bovis Natural, PW Tochimoto/Toyama Mexico 2001
7 Natural C.bovis Natural, PW Tochimoto/Toyama Kenya 2001
8 Natural C.bovis Natural, CL
2) Takahashi K .
3) China 2007
9 Natural C.bovis Natural, CL Osaka univ.
4) India 1978
10 Artificial C.bovis In vitro prepared, PW Takahashi K . China 2007
11 Artificial C.bovis In vitro prepared, PW Osaka univ. China 1971
12 Artificial cultured C.bovis In vitro cultured, CL Tochimoto co. China, Hubei 2009
13 Artificial cultured C.bovis In vitro cultured, CL Tochimoto co. China, Anhui 2009
The abbreviations of properties:
1) PW: powder,
2)CL: clod.
3) Samples were purchased from local stores in Shenyang by Takahashi K.
4) Historical specimens stored
in the museum of Osaka University.
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Calculus Bovis
Primary cultures of cardiac cells from 1-day-old Wister
rats were prepared according to the methods described
previously [7]. All experimental procedures were
approved by the Animal Care Committee of Osaka Uni-
versity and conformed to international guidelines.
Cardiac cells were seeded in a 96-well plate and were
determined by MTS assay using CellTiter 96® aqueous
one solution reagent (Promega Corporation) [8]. After
48 h incubation in serum-containing culture medium,
medium was transferred to serum-free medium. After
24h incubation, cells were treated with C. Bovis, bile
acids and taurine for 48h. Following removal of the
C. Bovis, cells were washed with phosphate-buffered sal-
ine (PBS) twice. The cells were then incubated in serum
free maintenance medium (100μl) with one solution
reagent (20μl) for 3h. Cell viability was defined as the
ratio (expressed as a percentage) of absorbance of trea-
ted cells to untreated cells at 490nm.
The beating status of cultured myocardial cells was
m o n i t o r e dw i t ha ni n v e r t e dp h a s e - c o n t r a s tm i c r o s c o p e
and was measured by using a photosenser equipped
with a microcomputer (P-200, Adachi Co.,Osaka). The
shape and location of each cell in the dish were
recorded before initiating the experiments [9]. The beat-
ing properties of the same cells were monitored follow-
ing the chosen perturbation.
Statistic analysis
Statistical significance was determined by the Student’s
t-test. Each value was expressed as the mean ± S.E. Dif-
ferences were considered statistically significant when
the calculated P value was less than 0.05.
Results
Quality characterization of Calculus Bovis using pattern
recognition techniques and multiple element data
It is an important issue to comprehensively evaluate the
different species of C. Bovis, so as to ensure the clinical
efficacy of this medicinal material. The provisions of
Chinese Pharmacopeia [4] for some substitutes of nat-
ural C. Bovis were summarized in Table 2. One has
been so-called artificial C. Bovis, being a mixture of bile
salts, bilirubin, taurine and some other ingredients that
have been found and believed to have contributed to the
therapeutic effects of natural C. Bovis. Another is the so-
called cultured C. Bovis, which is either the induced
gallstones in animals in vivo, or those produced in vitro
under the conditions mimicking the gallstone formation
process in vivo [2].
On the other hand, reference values for C. Bovis in
Japanese Pharmacopeia [10] is as follows: spherical or
massive stone, 1-4 cm in diameter; externally yellow-
brown to red-brown; light, fragile and easily broken.
Fractured surface shows yellow-brown to red-brown
annular rings, often containing white granular sub-
stances or thin layers in these annular rings. Odor,
slight; taste, slightly bitter, followed by slight sweetness.
Namely, the form, colour, smell and very importantly
the taste are some of the sensory indicators, on the
basis of traditional knowledge, to test for quality.
Therefore, mulitiple elements in C. Bovis materials of
natural and substitutes were determined by using ICP-
MS. Eighteen element patterns for each sample of
C. Bovis were illustrated in Figure 1. High differences
can be observed in the elemental composition among
the samples, especially for some elements such as Zn
and Al. Na and Mn are similar components in the sam-
ples of natural C. Bovis. Australian samples were com-
posed of fewer elements without toxic metals such as
As and Hg.
In total, 18 elements were determined in a range of 13
samples (9 natural C. Bovis, 4 artificial substitutes). The
result indicated the variation among C. Bovis samples
under different developmental conditions (Figure 2).
PCA can classify 13 samples as shown in Figure 2-A.
Thirteen samples were separated by their origin, Austra-
lian materials, other countries and substitutes. Austra-
lian materials were classified in the group of samples
from other countries. The elements, Mn, Zn and Al,
were found by PCA to contribute the classification of
13samples. A satisfactory classification using SIMCA
was obtained both for Australia C. Bovis and the
substitutes, namely 100 % of cases correctly classified
(Figure 2-B).
Table 2 Charcteristics of Calculus Bovis in Chinese
Pharmacopoeia 2005
Crude drugs Ingredients Compounds
Natural Calculus
Bovis,
Niuhuang
CALCULUS BOVIS
Bos taurus domesticus Gmelin CA : ≥ 4.0%
Bilirubin ≥ 35.0%
Total ash ≤
10.0%
Artificial Calculus
Bovis
Rengong Niuhuang
CALCULUS BOVIS
ARTIFACTUS
Ox bile-powder (CA: ≥ 42.0%)
Cholic acid:CA ( ≥ 80.0%)
Hyodeoxycholic acid:HCA
Taurine
Bilirubin ( ≥ 90%)
Cholesterol, Trace elements
CA : ≥ 13.0%
Bilirubin : ≥
0.63%
In-vitro cultured
Calculus Bovis
Tiwai Peiyu
Niuhuang
CALCULUS BOVIS
SATIVUS
Fresh bile of Bos taurus
domesticus Gmelin
Cholic acid:CA ( ≥ 95.0%)
Ca Bilirubinacet complexes
(C A≥ 43.0 %)
Deoxycholic acid:DCA ( ≥95.0
%)
CA : ≥ 6.0%
Bilirubin : ≥
35.0%
China Pharmacopoeia Committee: Pharmacopoeia of the People’s Republic of
China, 1
st Div (2005 edition) Beijing, China Chemical Industry Press 2005
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Bovis
In this study, we have used natural C. Bovis originated
from Australia for ensuring its efficacy. The major con-
stituents of this extract were bile acids (cholic acid: CA,
deoxycholic acid: DCA, taurocholic acid:TCA) and taur-
ine. The average bile acid concentration in Australian
C. Bovis extract (0.1mg/ml ) was equivalent to 0.32 mM
CA,0.32mM DCA and 0.24 mM TCA, respectively (not
data shown).
To assess whether C.Bovis extract had cytotoxic effects
on cardiac cells, morphological injury and cell viability
using MTS assay were measured. Figure 3-A showed the
influence of different doses of C.Bovis extract on the
morphology of cultured cardiomyocytes. Addition of C.
Bovis extract to the culture medium to give a final con-
centration of 0.01-0.1mg/ml had no change during 24 h
(Figure 3-A). At the dose of 0.1 mg/ml, treatment with
C.Bovis extract for 48 h barely influenced the growth of
cardiac myocytes and fibroblasts despite the bile acid
contents of 0.2~0.3mM (Figure 4). The presence of
1mM DCA showed pronounced injury, including bal-
looning and cell lysis on cardiac myocytes and fibro-
blasts after 1 h (Figure 3-B).
Cardiac myocytes and fibroblasts treated for 48 h with
CA or DCA caused cell injury, as reflected by changes
in appearance and a reduction of viability detected by
the MTS assay (Figure 4). The cell viability of both cells
was reduced by approximately 70 % when the cells were
treated with 0.1mM DCA, whereas TCA at a concentra-
tion of 0.5 mM had no effect over a 48-h period. Treat-
ment with 0.5 mM CA caused a decrease in viability of
fibroblasts by 66 % of control after 48 h. Cardiomyocyte
was not significantly altered its viability by treatment
with 0.5 mM CA for 48 h.
Figure 5 shows a typical photograph and the beating
status recorded by a photosensor equipped with micro-
computer on cardiomyocytes. Changes in morphology
and beating status were estimated for each cell on
12 points and expressed as percent of the total points of
Figure 1 Multiple element patterns of natural Calculus Bovis samples derived from different habitats. The number in parentheses
matched to the number of samples in Table 1. The elements which were detected more than 1 ng/l in the solvent were selected. Each data in
the chart was shown as relative concentration. Relative concentration was calculated by setting the maximum concentration of each element
contained in samples as 1 (n=3).
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Page 4 of 9cells observed (not data sown). As shown Figure 5-B-d,
untreated cells showed the rhythmic beating detected by
vertical displacements. There is no significant inhibition
on the beating status when 0.1 mg/ml of C.Bovis extract
is administered (Figure 5-B-f). All cells in observed
12 points with/without C.Bovis kept to beat synchro-
nously over a 3 h period without morphological changes.
However, CA at a concentration of 0.5 mM caused a 50 %
beat cessation of cardiomyocytes (Figure 5-B-e).
In China Pharmacopoeia, bile acids are the major
active components and CA has been used as the chemi-
cal marker for quality control of C. Bovis and its substi-
tutes [4]. Taurine is also provided as an ingredient of
artificial C. Bovis. In the present study, taurine content
in several samples of natural C. Bovis and its substitutes
varied widely between 0.035~104.7 mg/g. The mean
taurine concentration for Australian natural C. Bovis in
the study was 0.32 ±0.19 mg/g C.Bovis (2.56 μmol/g).
The values for the highest and lowest taurine concentra-
tions were 3.92 mg/g of Chinese and 0.035 mg/g of
Mexican one, respectively.
We have previously reported on the anti-arrhythmic
actions of C. Bovis and suggested these effects are partly
mediated by 0.1 mM-taurine [3]. Therefore, we tested
the effects of taurine on CA-induced beating abnormal-
ity. In cardiomyocytes, 0.5 h exposure of CA markedly
decreased the velocity ratio of beating from 69% to 18%,
whereas the simultaneous addition of 1 mM taurine
largely prevented the decrease, restoring the beating
ratio to 47% (Figure 6).
Discussion
Natural C. bovis is obtained as a valuable by-product
from animals used for meat production. As the natural
occurrence is very rare, great efforts have been taken for
some substitutes of natural C. Bovis. In 2004, it was
reported that 98 % of C. Bovis used in China was artifi-
cial [2]. However, due to the different developmental
conditions, chemical constituents of substitutes might
be different from those natural C. Bovis, which thus may
lead to the variation of therapeutic effects. In Japan, all
materials of C. Bovis are imported from several coun-
tries such as Australia, Latin America, Africa, India and
China [11]. Empirically, Japanese importers evaluated
Australian C. Bovis as a high quality product without
scientific reasons. The disordered use and abuse result
in the loss of original pharmaceutical actions and thera-
peutic values of this natural product. Therefore, to
ensure the quality of C. Bovis and its substitutes, an effi-
cient quality control approach is urgently needed. Cor-
rectly characterizing the traditional animal materials is
the inevitable starting point for studying C. Bovis.
First, we have characterized Natural C. Bovis originat-
ing from Australia using pattern recognition techniques
and major and trace elements data (Figure 1, 2). PCA
and multi-elemental focus was effective in discriminating
Figure 2 Quality characterization of Calculus Bovis using pattern recognition techniques and multiple element data. (A) PCA score plot
according to multiple element data. The number in parentheses matched to the number of samples in Table 1. Variables such as Na, Mg, Al, K,
Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ge, As, Mo, Hg and Pb have been used as discriminating factors. Percentages in square brackets were
contribution values. (B) Multivariate characterization by SIMCA. Symbols: Australian C. Bovis;( ●); other countries (○); artificial samples (▲). Each
point represented the mean values. (n = 3).
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Page 5 of 9Figure 3 Morphological changes of cardiac cells induced by Australian Calculus Bovis and deoxycholic acid. (A) Cardiomyocytes were
incubated with increasing concentrations of Australian C. Bovis-extract: (a) 0 mg/ ml; (b) 1x10
-2 mg/ml; (c) 5x10
-2 mg/ml; (d) 1x10
-1 mg/ml. The
morphological changes of cardiomyocytes were recorded using phase contrast micrographs observed at a magnification of x100. (B) Cells were
exposed to medium containing DCA (0.1 mM). Cardiac myocytes: (e) 0 h, (f) 1 h. Cardiac fibroblasts: (g) 0 h, (h) 1 h.
Figure 4 Influences of Calculus bovis -related substances on viability of cardiac cells. Cells were incubated with C. Bovis-ext. and three bile
acids for 48 h. Values were expressed as percent of control, in which the control cells were untreated. Data expressed means ±SEM obtained
from of 12-14 samples from triplicate experiments. Cardiac fibroblasts (A) and myocytes (B) were treated with C. Bovis (1x10
-1 mg/ml), DCA (0.1
mM), TCA (0.5 mM) and CA (0.5 mM), respectively. **P<0.01 compared with C. Bovis-ext.
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Page 6 of 9C. Bovis samples derived from different habitats. There is
general agreement among the experts/importers on
crude drugs that Australian C. Bovis is quite a good qual-
ity on the basis of traditional knowledge. Interestingly,
natural grouping of Australian samples was observed
(Figure 2). Namely, the Australian ones had better batch
uniformity than other habitats and were composed of
fewer elements. The result indicated the variation among
C. Bovis samples under different developmental condi-
tions such as natural or artificial.
Secondly, we have used Australian C. Bovis for assess-
ment on its bioactive compounds. Chemical and pharma-
cological investigations on C. Bovis resulted in discovering
several kinds of bioactive components, i.e.b i l ea c i d s ,b i l i r u -
bin and some inorgamic salts [1,12,13]. CA has been used
as the chemical marker for quality control of C. Bovis in
the provisions of Chinese Pharmacopeia (Table 2) [4].
T a u r i n ea n dC Aa r ea l s oo n eo ft h ei n g r e d i e n t sf o ra r t i f i c i a l
substitutes (Table 2) [4]. Since the content of CA,DCA and
taurine in C. Bovis extract derived from different sources
can vary enormously, its effect on cardiomyocytes needs to
be analyzed after normalization based the value of taurine
or CA/DCA. This is particularly important because CA/
DCA and taurine have opposite effect on cardiomyocytes.
Figure 5 Effects of cholate and Calculus bovis on beating of cardiac myocytes. Cardiomyocytes were exposed to medium containing CA or
C.Bovis-extract for 3 h. The morphological changes (A) and beating status (B), untreated cells, (a, d); CA 0.5 mM, (b, e); C.Bovis-extract 1x10
-1 mg/
ml, (c, f).
Figure 6 Effect of taurine on the beat inhibition of
cardiomyocytes induced by cholic acid. Cells were incubated for
0.5 h in medium containing CA (0.5 mM) and taurine (1 mM). Data
were expressed as means ±SEM obtained from of 20 samples from
triplicate experiments. *P<0.01 compared with control, **P<0.01
compared with CA.
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DCA caused cell injury, as reflected by the morphologi-
cal change and a reduction of cell viability (Figure 3, 4).
Rat cardiac cells incubated with C. Bovis extract (0.01-
0.1mg/ml) maintained a normal morphology, viability
and beating pattern (Figure 3, 4, 5). However, cardiac
cells treated with CA or DCA caused cell injury, as
reflected by the morphological change and a reduction
of cell viability. TCA, a major constituent in C. Bovis,
also caused loss of synchronous beating, bradycardia
and cessation of contraction in cultured rat cardiomyo-
cytes [14,15]. We demonstrated a reduced rate of con-
traction and proportion of beating cells when rat
cardiomyocytes were exposed to CA. 0.5 h exposure of
CA markedly decreased the velocity ratio of beating,
whereas the simultaneous addition of 1 mM taurine sig-
nificantly prevented the decrease (Figure 6). Our pre-
vious data reported that C. Bovis extract was effective in
protecting against the abnormal beating induced high
Ca
2+, and its efficacy was interfered by an inhibitor of
taurine transport, bata-alanine [3,16]. It has been recog-
nized that taurine may have some beneficial effects due
to, for instance, its antioxidant or anti-apoptotic capacity
[17-20]. It is plausible that the relationship between
taurine and the bile acids contribute to the therapeutic
effect of C. Bovis.
Finally, this work provided some references for the
quality control of C. Bovis materials. For practical pur-
poses and for conservation reasons [21], it is desirable
to find acceptable substitutes to C. Bovis used in tradi-
tional medicines. And it is necessary to make use of
modern scientific tools to establish verifiable synthetic
substitutes as sustainable replacements for medicinal
resources. Future work would be focused on the differ-
ent pharmacological actions of these natural C. Bovis
and the substitutes of some spurious breeds.
Conclusions
The present work provided some references for the
quality control and the efficacy of C. Bovis.P C Aa n d
multi-elemental focus was effective in discriminating
C. Bovis samples derive from different habitats. Taurine
partly attenuated the harmful actions of bile acids. It is
plausible that the relationship between taurine and the
bile acids contribute to the therapeutic effect of C. Bovis.
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